Predictors of left ventricular function after acute myocardial infarction: Effects of time to treatment, patency, and body mass index: The GUSTO-I angiographic experience

American Heart Journal

Volumn 142, Issue 1, 2001, Pages 43-50

  Lundergan, Conor F ^a   Ross, Allan M ^a   McCarthy, William F ^a   Reiner, Jonathan S ^a   Boyle, Deneane ^a   Fink, Cynthia ^a   Califf, Robert M ^b   Topol, Eric J ^c   Simoons, Maarten L ^d   Van Den Brand, Marcel ^d   Van De Werf, Frans ^e   Coyne, Karin S ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b DUKE UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTERY BLOOD FLOW; ARTICLE; BODY MASS; CLINICAL TRIAL; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; HUMAN; HYPERKINESIA; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034948951     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2001.116076     Document Type: Article

References (36)

1. The effect of intravenous thrombolytic therapy on left ventricular function: A report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI phase 1) trial
2. Determinants of improved left ventricular function after thrombolytic therapy in acute myocardial infarction
3. Early recovery of left ventricular function after thrombolytic therapy for acute myocardial infarction: An important determinant of survival
4. Tissue plasminogen activator: Toronto (TPAT) placebo controlled randomized trial in acute myocardial infarction
5. Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction
6. Multicenter trial off anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: Effects on infarct size and left ventricular function
7. Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: Results of phase 1 Thrombolysis in Myocardial Infarction (TIMI) trial
8. Systolic left ventricular function after reperfusion therapy for acute myocardial infarction: An analysis of determinants of improvement
9. The effects of tissue plasminogen activator, streptokinase or both on coronary artery patency, ventricular function, and survival after acute myocardial infarction
10. Long term benefit of early thrombolytic therapy in patients with acute myocardial infarction: 5 year follow-up of a trial conducted by the Interuniversity Cardiology Institute of the Netherlands
11. Insights derived from the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) trials
12. Long term prognostic importance of patency of the infarct related artery after thrombolytic therapy for acute myocardial infarction
13. Thrombolysis in myocardial infarction (TIMI) trial, phase 1: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase
14. The use of biplane angiography for the measurement of left ventricular volumes in man
15. Left ventricular segmental wall motion - A new method using local direction information
16. Predictors of 30 day mortality in the era of reperfusion for acute myocardial infarction: Results from an international trial of 41,021 patients
17. A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty
18. Early beneficial effect of streptokinase on left ventricular function in acute myocardial infarction
19. Factors determining improvement in left ventricular function after reperfusion therapy for acute myocardial infarction: Primacy of baseline ejection fraction
20. The wavefront phenomenon of ischemic cell death, 1: Myocardial infarct size versus duration of coronary occlusion in dogs
21. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion
22. Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction
23. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction
24. Acute reduction in functional infarct expansion with late coronary reperfusion: Assessment with quantitative two-dimensional echocardiography
25. Coronary recanalization by elective angioplasty prevents ventricular dilatation after acute myocardial infarction
26. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction
27. Time from symptom onset to treatment and outcomes after thrombolytic therapy
28. Indications for fibrinolytic therapy in acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients
29. GISSI-2: A factorial randomized trial of alteplase vs streptokinase heparin vs no heparin among 12,490 patients with acute myocardial infarction
30. Myocardium at risk and infarct size after thrombolytic therapy for acute myocardial infarction: Implications for the design of randomized trials of acute intervention
31. Functional improvement of jeopardized myocardium following intracoronary streptokinase infusion in acute myocardial infarction
32. Clinical predictors of early infarct related artery patency following thrombolytic therapy: Importance of body weight, smoking history and infarct related artery
33. Classification and evaluation of the obesities
34. TIMI frame count: A quantitative method of assessing coronary artery flow